SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. [2395.T]
TOKYO, Apr 30 (Pulse News Wire) – Shin Nippon Biomedical Laboratories,ltd. (2395.T) resolved today to propose amendments to its articles of incorporation aimed at enhancing corporate governance and facilitating future management flexibility at its upcoming annual general meeting scheduled for April 30, 2026.
The proposed changes, which will be presented at the 53rd regular shareholders' meeting set for June 26, 2026, involve modifications to Articles 15 and 22 of the existing articles of incorporation. Specifically, the amendments would shift the authority to convene shareholder meetings and board meetings from the president to the chairman of the board.
Additionally, in cases where the chairman or president is unavailable, the vice president would take over these responsibilities, with further succession outlined in the revised articles. Shin Nippon Biomedical's resolution underscores its commitment to robust corporate governance structures, ensuring smoother operations and decision-making processes moving forward.
🟡 Confidence: Standard AI-translated content.